Q2IBB3 AF NFT

Cystic fibrosis transmembrane conductance regulator

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeicvg67ljz3fu5ize4wztw7kozczfvs7l33zlsg3cwmdw6edcdywti/metadata.json
IPFS of structure file: 
bafybeigzajnuy4enfkrugjw54rx7dqg6lvogtuwndbsfb4ow5gpfty7v6a/AF-Q2IBB3-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x01e98F6aA2b8835b76ABa5D63df70C33997ED954
First NFT owner address (bech32): 
genesis1q85c764zhzp4ka4t5htrmacvxwvhak257tsq8u
Current NFT ID #58993 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
58993
Accession (UniProt):
Q2IBB3
Name::
Cystic fibrosis transmembrane conductance regulator
Experimental Method:
Predicted structure
Sequence source:
Rhinolophus ferrumequinum

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q2IBB3 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q2IBB3|CFTR_RHIFE Cystic fibrosis transmembrane conductance regulator OS=Rhinolophus ferrumequinum OX=59479 GN=CFTR PE=3 SV=1 MQRSPLEKASVISKLFFSWTIPILKKGYRQRLELSDIYQISSADSADNLSEKLEREWDRELASKKNPKLINALQRCFFWRFTFYGILLYLGEVTKAIQPLLLGRIIASYDPDNKMERSIAIYLGIGLCLLFIMRTLLLHPAIFGLHHIGMQMRIALFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVMLLMGLLWELLQASAFCGLAFLIVLALLQAGLGRMMMKYRDQRAGKINERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELRLTRKAAYVRYVNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQEFLQKQEHKTLEYNLTTTEVVMENVTAFWEEGVGELFENAKQNNNSGNISSGDNRLFFSNFAILSTPVLRGINFKVERGQLLAVAGSTGAGKTSLLMMIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFERCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELLNLRPDFSSKLMGYDSFDQFSAERRNSILTETLRRFSFEGDAAGPWNEPKKQSFKQTGEFGEKRKSSVLNPINAIKRFSIVQKTPLQMNGIEEDSEESSERRLSLVPDSEQGETILPRSNLINTGPTFQGRRRQSVLNLMTHSSVNQGQIVHRSTAASTRKMSLAPQENFTEMDIYSRRLSQDNGLEISEEINEEDLKECLFDDLESIPAVTTWNTYLRYITVHKNLIFVLIWCLVIFLAEVAASLVAFWLIEKTRPQDKGNSTRSTNNTSPVIITSTSAFYMFYIYVGVADSLLALGFLRGLPLVHTLITVSKILHQKMLHSVLHAPMSTLNTLKAGAILNRFSKDIAILDDLLPLTIFDFIQLVLIVIGAVVVVSILKPYIFLAAVPVIIAFVILRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTATWFLYLSTLRWFQMRIEMIFVVFFVAVTFISILTTGEGEGTVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPAEESKYTKSVKPYKDGQLSKVMILENQHVKKDDIWPSGGQITVKDLTAKYIDGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSALLRLLNTEGEIQVDGVSWESVTVQQWRRAFGVIPQKVFIFSGTFRKNLDPYGQWNDQEIWKVADEVGLRSVIEQFPGNLDFVLVDGGFVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPITYQIIRRALKQAFADCTVILCEHRIEAMLECQRFLVIEENKVRQYDSMQKLLSEKSLFQQAISPSDRLKLFPQRSSSKHRSRAQITALKEEAEEEVQDTRL